POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 68 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,134,134 | -22.9% | 4,667,786 | +4.8% | 0.00% | 0.0% |
| Q2 2023 | $40,365,499 | +25.4% | 4,455,353 | +0.6% | 0.00% | 0.0% |
| Q1 2023 | $32,189,997 | +0.5% | 4,427,785 | +0.8% | 0.00% | 0.0% |
| Q4 2022 | $32,017,118 | +6.9% | 4,391,923 | +13.3% | 0.00% | 0.0% |
| Q3 2022 | $29,957,000 | +27.6% | 3,875,322 | +12.4% | 0.00% | 0.0% |
| Q2 2022 | $23,486,000 | -7.9% | 3,448,705 | +7.8% | 0.00% | 0.0% |
| Q1 2022 | $25,506,000 | +219.3% | 3,200,215 | +124.4% | 0.00% | – |
| Q4 2021 | $7,987,000 | -28.8% | 1,426,175 | -2.3% | 0.00% | – |
| Q3 2021 | $11,224,000 | – | 1,459,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,560,984 | $27,526,000 | 6.63% |
| Fairmount Funds Management LLC | 2,833,950 | $21,906,000 | 3.85% |
| JOHNSON & JOHNSON | 1,000,000 | $7,730,000 | 2.28% |
| BVF INC/IL | 5,590,048 | $43,211,000 | 1.78% |
| Affinity Asset Advisors, LLC | 746,576 | $5,771,000 | 1.61% |
| Sio Capital Management, LLC | 544,545 | $4,209,000 | 1.34% |
| PFM Health Sciences, LP | 4,515,216 | $34,903,000 | 1.26% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,052,842 | $8,138,000 | 1.13% |
| Boxer Capital, LLC | 2,500,000 | $19,325,000 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $2,319,000 | 0.78% |